This clinical trial is focused on studying the effects of a medication called doxycycline on certain bacterial infections that are sexually transmitted, such as chlamydia, gonorrhea, and syphilis. The study will use a form of doxycycline known as Doxycycline EG 200 mg Tabletten, which is taken orally as a tablet. The purpose of the study is to see if taking doxycycline after being exposed to these infections can affect how bacteria in the body respond to the medication over time.
Participants in the study will take doxycycline as a preventive measure after potential exposure to these infections. The study will monitor changes in the bacteria found in the body, particularly in the intestines, to see if they become less sensitive to doxycycline. This is important because it helps understand if the bacteria are developing resistance to the medication, which could make it less effective in the future.
The study will last for several months, with participants being observed for changes in the bacteria at different points, including at the start and after 180 days. The researchers will also look at how other bacteria, such as E. coli and K. pneumoniae, respond to doxycycline and other antibiotics like ceftriaxone and ciprofloxacin. This information will help determine the impact of using doxycycline as a preventive treatment on the overall resistance of bacteria to antibiotics.



Belgium